Skip to main content
. 2019 Aug 16;18(4):4237–4245. doi: 10.3892/ol.2019.10765

Figure 3.

Figure 3.

Expression of key genes in prostate cancer and normal prostate tissues. (A-D) The mRNA expression of the key genes was obtained from GEPIA (http://gepia.cancer-pku.cn/), including (A) GOLM1 (http://gepia.cancer-pku.cn/detail.php?gene=GOLM1), (B) MIA3 (http://gepia.cancer-pku.cn/detail.php?gene=MIA3), (C) ACLY (http://gepia.cancer-pku.cn/detail.php?gene=ACLY) and (D) GNB2 (http://gepia.cancer-pku.cn/detail.php?gene=GNB2). Red data columns represent prostate cancer; black data columns represent normal prostate tissues; T, tumor; N, normal. (E-L) Immunohistochemistry images of protein expression of genes were obtained from the Human Protein Atlas (https://www.proteinatlas.org/), including (E) GOLM1 (https://www.proteinatlas.org/ENSG00000135052-GOLM1/pathology/tissue/prostate+cancer#img), (F) MIA3 (https://www.proteinatlas.org/ENSG00000154305-MIA3/pathology/tissue/prostate+cancer#img), (G) ACLY (https://www.proteinatlas.org/ENSG00000131473-ACLY/pathology/tissue/prostate+cancer#img) and (H) GNB2 (https://www.proteinatlas.org/ENSG00000172354-GNB2/pathology/tissue/prostate+cancer#img) in prostate cancer tissues, and (I) GOLM1 (https://www.proteinatlas.org/ENSG00000135052-GOLM1/tissue/prostate), (J) MIA3 (https://www.proteinatlas.org/ENSG00000154305-MIA3/tissue/prostate), (K) ACLY (https://www.proteinatlas.org/ENSG00000131473-ACLY/tissue/prostate) and (L) (https://www.proteinatlas.org/ENSG00000172354-GNB2/tissue/prostate) in control tissues. Magnification, ×40. *P<0.05. PRAD, prostate cancer; control, normal prostate tissues; GOLM1, Golgi membrane protein 1; MIA3, melanoma inhibitory activity member 3; ACLY, ATP citrate lyase; GNB2, G protein subunit β2.